Maureen Brady
Papers
4
Total Citations
21
H-Index
2
About
Dr. Maureen Brady is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for esophageal and gastroesophageal junction cancers. Her major contributions lie in refining robotic-assisted esophagectomy, particularly the Ivor Lewis approach, to improve patient outcomes. In her landmark 2022 matched-pair cohort analysis (15 citations), she demonstrated that robotic surgery offers significant advantages over conventional thoracolaparoscopic methods, including reduced morbidity. She has further validated these findings through a large single-center series of 150 consecutive patients, showing that robotic assistance consistently achieves "textbook outcomes"—a composite measure of ideal postoperative recovery. Dr. Brady has also advanced the understanding of optimal lymph node dissection, notably establishing the relevance of subcarinal node clearance for junctional adenocarcinomas (2023). Her technical expertise is showcased in her work on robotic enucleation of large leiomyomas (2021), highlighting her ability to manage complex tumors with precision. With a growing citation impact and a focus on evidence-based surgical innovation, Dr. Brady is shaping the future of esophageal cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Robotic Enucleation of a Large Gastroesophageal Junction Leiomyoma2 citations · 2021